In this highly radiosensitive model, the control of the irradiated tumor and the levels of CD8 + tumor-infiltrating lymphocytes (TILs) exhibited no significant variance between the RT/IL-2c combination and RT monotherapy groups. This evidence concerns the gene CD8A and neoplasm.